Compare CVKD & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVKD | HCTI |
|---|---|---|
| Founded | 2022 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.0M |
| IPO Year | 2022 | 2021 |
| Metric | CVKD | HCTI |
|---|---|---|
| Price | $1.71 | $2.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 103.3K | 96.9K |
| Earning Date | 11-16-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.94 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,891,000.00 |
| Revenue This Year | N/A | $179.58 |
| Revenue Next Year | N/A | $4.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 18.77 |
| 52 Week Low | $0.82 | $0.14 |
| 52 Week High | $12.50 | $9.97 |
| Indicator | CVKD | HCTI |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 47.07 |
| Support Level | $0.88 | $2.18 |
| Resistance Level | $2.23 | $3.41 |
| Average True Range (ATR) | 0.21 | 0.65 |
| MACD | 0.07 | -0.29 |
| Stochastic Oscillator | 78.44 | 4.32 |
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.